Inhibition of Sema4D in HN6 cells using shRNA, significantly reduced the level of activated TGF-β1 in the CM of the tumor cells to levels comparable to NOK and to that present in normal cell culture medium (Figure 3H). The gene discussed is SEMA4D; the disease is neoplasm.